Cut weeks from screening to enrollment.
AI-assisted qualification routes the right candidates to the right protocols faster — shrinking the screening funnel without sacrificing data quality.
CASExAI
AI-driven platform that streamlines patient identification, enrollment, engagement, and retention — from screening through study close.
Featuring SKYE (AI study coordinator) and SARA (ePROs mobile app), plus a complete CTMS backbone and Mobile Retina Clinic integration to accelerate trial operations end-to-end.
Capabilities
CASExAI brings together a CTMS backbone, AI-assisted coordination, patient-facing apps, and mobile clinic capabilities — purpose-built for retina and ophthalmic trials but applicable across therapeutic areas.
Foundational AI engine that powers patient identification, study optimization, evidence generation, and clinical decision support across the trial lifecycle.
Centralize trial data, milestones, and operations in one auditable, sponsor-ready platform.
Reduce screening-to-enrollment time with AI-assisted patient qualification and routing.
Accelerate enrollment velocity through smarter outreach and qualified-candidate prioritization.
Augment site coordinators by automating routine workflows and surfacing trial-data insights.
Capture longitudinal patient-reported outcomes via mobile app with high engagement and adherence.
Bring trial activities directly to patients with mobile clinic capability tailored for retina studies.
Strengthen site relationships through dashboards, proactive support, and operational transparency.
Build durable patient pipelines through targeted referral partnerships and recruitment outreach.
Why CASExAI
Clinical operations is where good science meets execution reality. CASExAI removes friction across enrollment, coordination, and patient engagement so sponsors can run trials that finish faster and produce cleaner evidence.
Cut weeks from screening to enrollment.
AI-assisted qualification routes the right candidates to the right protocols faster — shrinking the screening funnel without sacrificing data quality.
Accelerate enrollment velocity.
Smarter outreach, qualified-candidate prioritization, and referral pipeline integration get more patients enrolled per week.
Keep patients engaged through study close.
SARA ePROs and the Mobile Retina Clinic reduce visit burden — boosting engagement and lowering dropout rates across the trial lifecycle.
Higher-quality longitudinal ePRO capture.
Digital ePRO via SARA captures patient-reported outcomes with high adherence — cleaner data with fewer manual-entry errors.
Coordinator capacity, freed for patient care.
SKYE automates routine workflows so site coordinators can focus on high-value patient interactions instead of paperwork.
A durable recruitment pipeline.
Targeted referral partnerships and site engagement tools build sustainable patient pipelines that scale across studies and indications.
— AI-Driven Clinical Platform —
Powered by AI-enabled tools including SKYE (a study coordinator assistant), SARA (a patient-reported outcomes mobile app), and a complete Clinical Trial Management System — CASExAI helps sponsors accelerate clinical operations while improving patient experience.
Spotlight Products
SKYE
An intelligent assistant that augments site coordinators — automating routine workflows, surfacing key insights from trial data, and freeing coordinator time for higher-value patient interactions.
SARA
A mobile app that captures patient-reported outcomes longitudinally — improving data quality, increasing patient engagement, and reducing dropouts across the trial lifecycle.
— Let's Work Together —
Tell us where you are in development and what you're trying to achieve. We'll follow up to explore how ClarezAI can help.